Yayınlar & Eserler

Yayın Ağı
Makaleler 18
Tümü (18)
SCI-E, SSCI, AHCI (14)
SCI-E, SSCI, AHCI, ESCI (15)
ESCI (1)
Scopus (18)
TRDizin (1)

1. The integration of the British Pharmacological Society's prescription safety assessment into the WHO 6‐step model of rational pharmacotherapy in a Turkish medical school

Gülmez S. E., Özcan G., Orer H. S.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY , sa.Epub ahead of print, ss.1, 2025 (SCI-Expanded, Scopus) identifier identifier identifier

2. Functional genomics reveals an off-target dependency of drug synergy in gastric cancer therapy

Leylek O., Honeywell M. E., Lee M. J., Hemann M. T., Özcan G.
GASTRIC CANCER , cilt.27, sa.6, ss.1201-1219, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

3. Brain lymphatic vessels accompanying meningeal arteries in the human

Çavdar S., Altınöz D., Demir T. D., Bayraktaroğlu A., Gürses İ. A., ÖZCAN G.
Translational Research in Anatomy , cilt.37, 2024 (Scopus) identifier

4. Extracranial transport of brain lymphatics via cranial nerve in human

Çavdar S., Altınöz D., Dilan Demir T., Ali Gürses İ., ÖZCAN G.
Neuroscience Letters , cilt.827, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

5. Cancer-associated fibroblasts: protagonists of the tumor microenvironment in gastric cancer

Ozmen E., Demir T. D., Özcan G.
FRONTIERS IN MOLECULAR BIOSCIENCES , cilt.11, ss.1-18, 2024 (SCI-Expanded, Scopus) identifier identifier identifier

6. The hypoxia-inducible factor-1α in stemness and resistance to chemotherapy in gastric cancer: Future directions for therapeutic targeting

ÖZCAN G.
Frontiers in Cell and Developmental Biology , cilt.11, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

7. PTCH1 and CTNNB1 emerge as pivotal predictors of resistance to neoadjuvant chemotherapy in ER+/HER2- breast cancer

ÖZCAN G.
Frontiers in Oncology , cilt.13, 2023 (SCI-Expanded, Scopus) identifier identifier identifier

8. SCUBE2 as a Marker of Resistance to Taxane-based Neoadjuvant Chemotherapy and a Potential Therapeutic Target in Breast Cancer

ÖZCAN G.
European Journal of Breast Health , cilt.19, sa.1, ss.45-54, 2023 (ESCI, Scopus, TRDizin) identifier identifier identifier

9. Comprehensive bioinformatic analysis reveals a cancer-associated fibroblast gene signature as a poor prognostic factor and potential therapeutic target in gastric cancer

Ucaryilmaz Metin C., ÖZCAN G.
BMC Cancer , cilt.22, sa.1, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

10. The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer

Metin C. U., ÖZCAN G.
Cancers , cilt.14, sa.11, 2022 (SCI-Expanded, Scopus) identifier identifier identifier

11. Achieving synergism in combination chemotherapy for gastric cancer treatment

Leylek O., Ozcan G.
MOLECULAR CANCER THERAPEUTICS , cilt.20, sa.12, 2021 (SCI-Expanded) identifier

12. Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity

Almammadov T., Atakan G., Leylek O., ÖZCAN G., GÜNBAŞ E. G., Kolemen S.
ACS Medicinal Chemistry Letters , cilt.11, sa.12, ss.2491-2496, 2020 (SCI-Expanded, Scopus) identifier identifier identifier

13. Adverse Drug Reaction Reporting Pattern in Turkey: Analysis of the National Database in the Context of the First Pharmacovigilance Legislation

ÖZCAN G., Aykac E., Kasap Y., Nemutlu N. T., Sen E., Aydinkarahaliloglu N. D.
Drugs - Real World Outcomes , cilt.3, sa.1, ss.33-43, 2016 (Scopus) identifier identifier

14. Effect of Nitric oxide on cardiacfunction: Review Nitrik oksidin kalp Işlevleri üzerine etkisi

Özcan G., Şahin E. A., DEMİREL YILMAZ E.
Turkiye Klinikleri Cardiovascular Sciences , cilt.28, sa.3, ss.99-117, 2016 (Scopus) Sürdürülebilir Kalkınma identifier

15. Preclinical and clinical development of siRNA-based therapeutics

ÖZCAN G., Ozpolat B., Coleman R. L., Sood A. K., Lopez-Berestein G.
Advanced Drug Delivery Reviews , cilt.87, ss.108-119, 2015 (SCI-Expanded, Scopus) identifier identifier identifier

16. Various Phosphodiesterase Activities in Different Regions of the Heart Alter the Cardiac Effects of Nitric Oxide

DEMİREL YILMAZ E., Cenik B., Ozcan G., Derici M. K.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY , cilt.60, sa.3, ss.283-292, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

17. Cell Contact-dependent Functional Selectivity of beta(2)-Adrenergic Receptor Ligands in Stimulating cAMP Accumulation and Extracellular Signal-regulated Kinase Phosphorylation

Kaya A. I., ONARAN H. O., Ozcan G., Ambrosio C., Costa T., Balli S., et al.
JOURNAL OF BIOLOGICAL CHEMISTRY , cilt.287, sa.9, ss.6362-6374, 2012 (SCI-Expanded, Scopus) Creative Commons License identifier identifier identifier

18. beta(2)-Adrenoceptor, Gs and adenylate cyclase coupling in purified detergent-resistant, low density membrane fractions

Oner S. S., Kaya A. I., ONARAN H. O., Ozcan G., Ugur O.
EUROPEAN JOURNAL OF PHARMACOLOGY , cilt.630, sa.1-3, ss.42-52, 2010 (SCI-Expanded, Scopus) identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 5

1. The integration of the British Pharmacological Society's Prescription Safety Assessment into the Groningen Model of Rational Pharmacotherapy in a Turkish Medical School

Orer H., Ozcan G., Gulmez S. E.
19th World Congress of Basic and Clinical Pharmacology (WCP), Glasgow, İngiltere, 2 - 07 Temmuz 2023, cilt.180, ss.624-625, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

2. Implementation of the British Pharmacological Society's Prescribing Safety Assessment (PSA) in a Turkish Medical School for Interns

Gulmez S. E., Ozcan G., Orer H.
19th World Congress of Basic and Clinical Pharmacology (WCP), Glasgow, İngiltere, 2 - 07 Temmuz 2023, cilt.180, ss.623-624, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

3. A Distinctive Stromal Reaction as the Herald of Uncertain Carcinoma Foci in the Peritoneal Frozen Sections of Post-Neoadjuvant Gastric Poorly Cohesive /Signet Ring Cell Carcinomas

Aktas B. K., Esmer R., Tezcan N., Taskin O., Armutlu A., Saka B., et al.
112th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP), Meksika, 11 - 16 Mart 2023, cilt.103, (Özet Bildiri) identifier

4. Fourth-year rational pharmacotherapy clerkship at Koc University School of Medicine

Gulmez S. E., Ozcan G., Orer H. S.
14th Congress of the European-Association-for-Clinical-Pharmacology-and-Therapeutics (EACPT), Stockholm, İsveç, 29 Haziran - 02 Temmuz 2019, cilt.75, (Özet Bildiri) Sürdürülebilir Kalkınma identifier

5. Concomitant Drug Use as a Contributing Factor for Developing Cardiovascular Adverse Reactions with Trandolapril/Verapamil Combination

Ozcan G., Aykac E., Kasap Y., Sen E., Nemutlu N., Artiran G., et al.
13th Annual Meeting of the International-Society-of-Pharmacovigilance (ISoP) - The Renaissance of Pharmacovigilance, Pisa, İtalya, 1 - 04 Ekim 2013, cilt.36, ss.845, (Özet Bildiri) Sürdürülebilir Kalkınma identifier
Kitaplar 1

1. Clinical Development of HIF-1α inhibitors for Cancer Therapy

ÖZCAN G.
Medical Diagnosis and Treatment Methods in Basic Medical Sciences, Keskin Sıddık, Editör, Livre de Lyon, Lyon, ss.25-37, 2020
Metrikler

Yayın

24

Yayın (WoS)

20

Yayın (Scopus)

18

Atıf (WoS)

558

H-İndeks (WoS)

7

Atıf (Scopus)

673

H-İndeks (Scopus)

8

Proje

4

Tez Danışmanlığı

4

Açık Erişim

1
BM Sürdürülebilir Kalkınma Amaçları